A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis(145 visite) Gentile I, Coppola N, Pasquale G, Liuzzi R, D'Armiento M, Di Lorenzo ME, Capoluongo N, Buonomo AR, Sagnelli E, Morisco F, Caporaso N, Borgia G
Hepat Mon (ISSN: 1735-143xprint, 1735-143xlinking), 2013 May 8; 13(5): e8352-e8352.
Tipo di articolo: Journal Article,
Impact factor: 1.796, Impact factor a 5 anni: 1.601
Parole chiave: Adult, Alanine Transaminase, Blood, Analysis Of Variance, Area Under Curve, Aspartate Aminotransferases, Biological Markers, Female, Hepatitis C, Chronic, Humans, Liver Cirrhosis, Diagnosis, Pathology, Logistic Models, Middle Aged, Platelet Count, Roc Curve, Severity Of Illness Index, Young Adult, Alpha-Fetoproteins, Metabolism, Biopsy, Fibrosis, Noninvasive Ventilation, Prothrombin, Alcohol Consumption, Article, Human Tissue, Liver Biopsy, Major Clinical Study, Predictive Value, Receiver Operating Characteristic, Scoring System, Sensitivity And Specificity, Splenomegaly, Thrombocyte Count,
Affiliazioni:
*** IBB - CNR *** Department of Clinical Medicine and Surgery, University of Naples Federico II, via S. Pansini, Naples, Italy., Department of Public Medicine, Section of Infectious Disease, Second University of Naples, Via L. Armanni, Naples, Italy Institute of Biostructure and Bioimaging, National Research Council (CNR), Naples, Italy Department of Advanced Biomedical Science, University of Naples Federico II, Via S. Pansini, Naples, Italy
Riferimenti:
Lavanchy, D., The global burden of hepatitis C (2009) Liver Int, 29 (SUPPL. 1), pp. 74-8
Global burden of disease (GBD) for hepatitis C (2004) J Clin Pharmacol, 44 (1), pp. 20-29
Coppola, N., Pisapia, R., Tonziello, G., Masiello, A., Martini, S., Pisaturo, M., Improvement in the aetiological diagnosis of acute hepatitis C: A diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index (2009) J Clin Virol, 46 (3), pp. 222-229
Hoofnagle, J.H., Hepatitis C: The clinical spectrum of disease (1997) Hepatology, 26 (3 SUPPL. 1), pp. 15S-20S
Garcia-Tsao, G., Sanyal, A.J., Grace, N.D., Carey, W., Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis (2007) Hepatology, 46 (3), pp. 922-938
Lok, A.S., Ghany, M.G., Goodman, Z.D., Wright, E.C., Everson, G.T., Sterling, R.K., Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT-C cohort (2005) Hepatology, 42 (2), pp. 282-292
Bedossa, P., Dargere, D., Paradis, V., Sampling variability of liver fibrosis in chronic hepatitis C (2003) Hepatology, 38 (6), pp. 1449-1457
Pagliaro, L., Rinaldi, F., Craxi, A., Di Piazza, S., Filippazzo, G., Gatto, G., Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective, randomized trial (1983) Dig Dis Sci, 28 (1), pp. 39-43
Regev, A., Berho, M., Jeffers, L.J., Milikowski, C., Molina, E.G., Pyrsopoulos, N.T., Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection (2002) Am J Gastroenterol, 97 (10), pp. 2614-2618
Siddique, I., El-Naga, H.A., Madda, J.P., Memon, A., Hasan, F., Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection (2003) Scand J Gastroenterol, 38 (4), pp. 427-432
Cadranel, J.F., Rufat, P., Degos, F., Practices of liver biopsy in France: Results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF) (2000) Hepatology, 32 (3), pp. 477-481
Janes, C.H., Lindor, K.D., Outcome of patients hospitalized for complications after outpatient liver biopsy (1993) Ann Intern Med, 118 (2), pp. 96-98
Perrault, J., McGill, D.B., Ott, B.J., Taylor, W.F., Liver biopsy: Complications in 1000 inpatients and outpatients (1978) Gastroenterology, 74 (1), pp. 103-106
Sagnelli, E., Sagnelli, C., Pisaturo, M.A., Coppola, N., Pasquale, G., Piccinino, F., Liver biopsy in chronic hepatitis C: The experience of 15 Italian wards of infectious diseases (2012) Infez Med, 20 (1), pp. 31-36
Poynard, T., Morra, R., Ingiliz, P., Imbert-Bismut, F., Thabut, D., Messous, D., Assessment of liver fibrosis: Noninvasive means (2008) Saudi J Gastroenterol, 14 (4), pp. 163-173
Rockey, D.C., Bissell, D.M., Noninvasive measures of liver fibrosis (2006) Hepatology, 43 (2 SUPPL. 1), pp. S113-S120
Ziol, M., Handra-Luca, A., Kettaneh, A., Christidis, C., Mal, F., Kazemi, F., Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C (2005) Hepatology, 41 (1), pp. 48-54
Imbert-Bismut, F., Ratziu, V., Pieroni, L., Charlotte, F., Benhamou, Y., Poynard, T., Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: A prospective study (2001) Lancet, 357 (9262), pp. 1069-1075
Patel, K., Friedrich-Rust, M., Lurie, Y., Grigorescu, M., Stanciu, C., Lee, C.M., FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus (2011) World J Gastroenterol, 17 (41), pp. 4581-4589
Berres, M.L., Schlosser, B., Berg, T., Trautwein, C., Wasmuth, H.E., Soluble urokinase plasminogen activator receptor is associated with progressive liver fibrosis in hepatitis C infection (2012) J Clin Gastroenterol, 46 (4), pp. 334-338
Fortunato, G., Castaldo, G., Oriani, G., Cerini, R., Intrieri, M., Molinaro, E., Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis (2001) Clin Chem, 47 (9), pp. 1696-1700
Ho, A.S., Cheng, C.C., Lee, S.C., Liu, M.L., Lee, J.Y., Wang, W.M., Novel biomarkers predict liver fibrosis in hepatitis C patients: Alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI (2010) J Biomed Sci, 17, p. 58
Kovalenko, E., Tacke, F., Gressner, O.A., Zimmermann, H.W., Lahme, B., Janetzko, A., Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis (2009) J Viral Hepat, 16 (9), pp. 612-620
Mehta, P., Ploutz-Snyder, R., Nandi, J., Rawlins, S.R., Sanderson, S.O., Levine, R.A., Diagnostic accuracy of serum hyaluronic acid, FIBROSpect II, and YKL-40 for discriminating fibrosis stages in chronic hepatitis C (2008) Am J Gastroenterol, 103 (4), pp. 928-936
Saitou, Y., Shiraki, K., Yamanaka, Y., Yamaguchi, Y., Kawakita, T., Yamamoto, N., Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease (2005) World J Gastroenterol, 11 (4), pp. 476-481
Selim, H.S., El-Barrawy, M.A., Taha, H.A., Abd El-Hafiz, D.A., Evaluation of Interleukin-18 as a Non Invasive Marker of Liver Fibrosis among Chronic Hepatitis C Virus Patients (2009) J Egypt Public Health Assoc, 84 (5-6), pp. 391-403
Valva, P., Casciato, P., Diaz Carrasco, J.M., Gadano, A., Galdame, O., Galoppo, M.C., The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection (2011) PLoS One, 6 (8), pp. e23218
Bonacini, M., Hadi, G., Govindarajan, S., Lindsay, K.L., Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection (1997) Am J Gastroenterol, 92 (8), pp. 1302-1304
Cross, T.J., Rizzi, P., Berry, P.A., Bruce, M., Portmann, B., Harrison, P.M., King's Score: An accurate marker of cirrhosis in chronic hepatitis C (2009) Eur J Gastroenterol Hepatol, 21 (7), pp. 730-738
Forns, X., Ampurdanes, S., Llovet, J.M., Aponte, J., Quinto, L., Martinez-Bauer, E., Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model (2002) Hepatology, 36 (4 Pt 1), pp. 986-992
Giannini, E., Risso, D., Botta, F., Chiarbonello, B., Fasoli, A., Malfatti, F., Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease (2003) Arch Intern Med, 163 (2), pp. 218-224
Imperiale, T.F., Said, A.T., Cummings, O.W., Born, L.J., Need for validation of clinical decision aids: Use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C (2000) Am J Gastroenterol, 95 (9), pp. 2328-2332
Islam, S., Antonsson, L., Westin, J., Lagging, M., Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers (2005) Scand J Gastroenterol, 40 (7), pp. 867-872
Kim, B.K., do, Y.K., Park, J.Y., Ahn, S.H., Chon, C.Y., Kim, J.K., Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients (2010) Liver Int, 30 (4), pp. 546-553
Lackner, C., Struber, G., Liegl, B., Leibl, S., Ofner, P., Bankuti, C., Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C (2005) Hepatology, 41 (6), pp. 1376-1382
Luo, J.C., Hwang, S.J., Chang, F.Y., Chu, C.W., Lai, C.R., Wang, Y.J., Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C (2002) Hepatogastroenterology, 49 (44), pp. 478-481
Park, G.J., Lin, B.P., Ngu, M.C., Jones, D.B., Katelaris, P.H., Aspartate aminotransferase: Alanine aminotransferase ratio in chronic hepatitis C infection: Is it a useful predictor of cirrhosis? (2000) J Gastroenterol Hepatol, 15 (4), pp. 386-390
Pohl, A., Behling, C., Oliver, D., Kilani, M., Monson, P., Hassanein, T., Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection (2001) Am J Gastroenterol, 96 (11), pp. 3142-3146
Sheth, S.G., Flamm, S.L., Gordon, F.D., Chopra, S., AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection (1998) Am J Gastroenterol, 93 (1), pp. 44-48
Wai, C.T., Greenson, J.K., Fontana, R.J., Kalbfleisch, J.D., Marrero, J.A., Conjeevaram, H.S., A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C (2003) Hepatology, 38 (2), pp. 518-526
Kaul, V., Friedenberg, F.K., Braitman, L.E., Anis, U., Zaeri, N., Fazili, J., Development and validation of a model to diagnose cirrhosis in patients with hepatitis C (2002) Am J Gastroenterol, 97 (10), pp. 2623-2628
Ishak, K., Baptista, A., Bianchi, L., Callea, F., de Groote, J., Gudat, F., Histological grading and staging of chronic hepatitis (1995) J Hepatol, 22 (6), pp. 696-699
Frank, K., Linhart, P., Kortsik, C., Wohlenberg H. [Sonographic determination of spleen size: Normal dimensions in adults with a healthy spleen] (1986) Ultraschall Med, 7 (3), pp. 134-137
Hanley, J.A., McNeil, B.J., The meaning and use of the area under a receiver operating characteristic (ROC) curve (1982) Radiology, 143 (1), pp. 29-36
Delong, E.R., Delong, D.M., Clarke-Pearson, D.L., Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach (1988) Biometrics, 44 (3), pp. 837-845
Gentile, I., Viola, C., Graf, M., Liuzzi, R., Quarto, M., Cerini, R., A simple noninvasive score predicts gastroesophageal varices in patients with chronic viral hepatitis (2009) J Clin Gastroenterol, 43 (1), pp. 81-87
Pradat, P., Voirin, N., Tillmann, H.L., Chevallier, M., Trepo, C., Progression to cirrhosis in hepatitis C patients: An age-dependent process (2007) Liver Int, 27 (3), pp. 335-339
Peck-Radosavljevic, M., Zacherl, J., Meng, Y.G., Pidlich, J., Lipinski, E., Langle, F., Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? (1997) J Hepatol, 27 (1), pp. 127-131
Gentile, I., Thabut, D., Noninvasive prediction of oesophageal varices: As simple as blood count? (2010) Liver Int, 30 (8), pp. 1091-1093
BACKGROUND: Liver biopsy has remained the gold standard for the diagnosis of chronic hepatitis C; even though, it has a low but non-negligible rate of both false negative and complications. Several authors have proposed noninvasive tools to diagnose cirrhosis. But none of them showed complete concordance with liver biopsy. OBJECTIVES: To devise a score based on noninvasive routine parameters that discriminate between patients with a high risk, and those with a low risk of cirrhosis among patients with chronic hepatitis C without performing liver biopsy, and to compare this score with other ones using routine parameters devoted to this aim. PATIENTS AND METHODS: We reviewed the charts of patients with chronic hepatitis C who performed a liver biopsy between 2000 and 2004. Multivariate analysis was used to identify independent predictors of cirrhosis. An independent group of patients with chronic hepatitis C admitted for a liver biopsy between 2007 and 2012 constituted the validation set. RESULTS: We enrolled 249 patients who had complete laboratoristic data, and sufficient liver tissue for fibrosis staging. Age, AST, prothrombin activity, and platelets were identified as independent predictors of histological cirrhosis. We categorized these variables, and devised a novel score called CISCUN (Cirrhosis Score University of Naples), giving one point to each of the following predictors: age > 40 years; AST > 2 upper normal values; platelet count < 160.000/mmc; prothrombin activity < 100%. Cirrhosis rate was 2.9% for the 103 patients with a CISCUN = 0 or 1, 23.4% for the 124 patients with a CISCUN of 2 or 3, and 86.4% for the 22 patients with a CISCUN = 4. These results were confirmed in the independent validation group of 285 patients with similar characteristics. CONCLUSIONS: Patients with chronic hepatitis C and with a CISCUN <!--= 1 had a very low rate of cirrhosis while those with a CISCUN = 4 had a high risk of cirrhosis. Patients with CISCUN = 2 or 3 had an intermediate rate of cirrhosis, and therefore needed to perform a liver biopsy to receive a reliable diagnosis.-->
Testino G, Leone S, Fagoonee S, Del Bas JM, Rodriguez B, Puiggros F, Marine S, Rodriguez MA, Morina D, Armengol L, Caimari A, Arola L, Cimini FA, Barchetta I, Carotti S, Bertoccini L, Baroni MG, Vespasiani-gentilucci U, Cavallo MG, Morini S, Nelson JE, Roth CL, Wilson LA, Yates KP, Aouizerat B, Morgan-stevenson V, Whalen E, Hoofnagle A, Mason M, Gersuk V, Yeh MM, Kowdley KV, Lee SM, Jun DW, Cho YK, Jang KS, Kucukazman M, Ata N, Dal K, Yeniova AO, Kefeli A, Basyigit S, Aktas B, Akin KO, Agladioglu K, Ure OS, Topal F, Nazligul Y, Beyan E, Ertugrul DT, Catena C, Cosma C, Camozzi V, Plebani M, Ermani M, Sechi LA, Fallo F, Goto Y, Ray MB, Mendenhall CL, French SW, Gartside PS Serum vitamin A deficiency and increased intrahepatic expression of cytokeratin antigen in alcoholic liver disease(27 visite) Hepatology (ISSN: 1827-1669electronic, 0026-4806linking), 1988 Sep; 83120693611123109(5): 1019-1026. Impact Factor:0.913 DettagliEsporta in BibTeXEsporta in EndNote
57 Records (52 escludendo Abstract e Conferenze). Impact factor totale: 196.078 (169.564 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 213.515 (184.54 escludendo Abstract e Conferenze).
ibb.cnr.it